Sapanisertib and Osimertinib in Treating Patients With Stage IV EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors

Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors